After Hours Summary: AAPL +3%, AMD +3%, ALGN +2.5% on earnings/guidance, Apple suppliers/tech names higher... MANH -2.5%, ILMN -1.5% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: OSTK +13%, ACXM +6.9%, FBHS +3.1% (ticking higher; also CFO Lee Wyatt will retire), AAPL +3%, AMD +2.8%, ALGN +2.5% (also files patent infringement lawsuit against ClearCorrect and Your Smile Direct in United Kingdom), CARB +2.3% (Carbonite acquired Double-Take Software for $65.25 mln and reports prelim Q4 results, issues FY17 guidance with Double-Take Software impact), WNC +2% (ticking higher), ALGT +1.2%, CB +1.1%, ARNC +0.9% (recoups early losses after Elliott Management confirmed has nominated five director candidates and outlined path for company in presentation)
Companies trading higher in after hours in reaction to news: XOMA +10% (established proof-of-concept for its product candidate 358 in congenital hyperinsulinism and hypoglycemia post-bariatric surgery), NSTG +8.8% (announces that Humana has issued a positive coverage decision for the Prosigna Breast Cancer Gene Signature Assay), MDT +1.8% (Bloomberg reporting that the company is mulling a sale of its medical-supplies unit), FB +0.7% (Facebook working to develop an app for TV set-top boxes, according to the WSJ),
Apple suppliers/tech names are higher: CRUS +2.3%, AVGO +1.8%, QRVO +1.2%, SWKS +0.8%, TXN +0.4%, MU +0.4%, NXPI +0.3%, INVN +0.2%, QCOM +0.2%After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: BBOX -13.9% (light volume), BOOT -10.1%, MTCH -5.6% (also sells non-dating business The Princeton Review to ST Unitas), TNAV -3.4% (light volume), MANH -2.5%, ILMN -1.5%, EA -1%, X -0.6%
Companies trading lower in after hours in reaction to news: CATB -66.6% (Catabasis Pharmaceuticals announces top-line safety and efficacy results for Part B of the MoveDMD trial of edasalonexent (CAT-1004) for the treatment of Duchenne muscular dystrophy), SGYP -12.4% (Synergy Pharma to sell $125 mln of common stock in a registered underwritten public offering), GALE -5.5% (announces Pres/CEO Mark W. Schwartz will resign effective today and the evaluation of strategic alternatives), AGI -3.9% (still checking), SN -3.4% (to commence an underwritten public offering of 10 mln shares of common stock), PMD -2% (pulling back after seeing late move higher when co issued press release claiming no ownership interest in Psychemedics Brasil-- still closed day significantly lower), DRYS -1.2% (modestly pulling back after confirming will release Q4 results February 7 after the close), AKS -0.6% and STLD -0.2% (X sympathy)